跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BEANAMINE EXPECTORANT - HSA Drug Approval Details
Approvals
/
HSA
/
BEANAMINE EXPECTORANT
Approved
THERAPEUTIC
BEANAMINE EXPECTORANT
BEACONS PHARMACEUTICALS PTE LTD (SINGAPORE)
🇸🇬 Health Sciences Authority
Approval Date
May 22, 1989
Approval ID
5e5823bb4d11018d
Company
BEACONS PHARMACEUTICALS PTE LTD (SINGAPORE)
Type
Therapeutic
Approval Details
Approval Id
5e5823bb4d11018d
Drug Name
BEANAMINE EXPECTORANT
Product Name
BEANAMINE EXPECTORANT
Approval Number
SIN02839P
Approval Date
1989-05-22
Registrant
BEACONS PHARMACEUTICALS PTE. LTD.
Licence Holder
BEACONS PHARMACEUTICALS PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PHARMACY ONLY MEDICINES
Dosage Form
SOLUTION
Route Of Administration
ORAL
Atc Code
R05FB01
Atc Item Name
cough suppressants and mucolytics
Pharma Manufacturer Name
BEACONS PHARMACEUTICALS PTE. LTD.
Active Ingredients
AMMONIUM CHLORIDE
0.12g/5 ml
DIPHENHYDRAMINE HCl
0.01 g/5 ml
AMMONIUM CHLORIDE
0.12 G/5 ML
DIPHENHYDRAMINE HCL
0.01 G/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 22, 1989
Approval ID
5e5823bb4d11018d
Type
Therapeutic
Back to HSA Approvals